Lucy Day
Director of Finance/CFO at AN2 THERAPEUTICS, INC.
Net worth: 99 538 $ as of 2024-03-30
Profile
Lucy O.
Day is currently the Chief Financial & Accounting Officer at AN2 Therapeutics, Inc. She also holds the position of Chief Financial Officer at the same company since 2019.
Prior to her current roles, she worked as Vice President at Bank of America Corp.
from 1990 to 1994.
From 1994 to 2002, she served as the Chief Financial Officer at Centaur Pharmaceuticals, Inc. Following that, she held the position of CFO, VP-Human Resources & Finance at Anacor Pharmaceuticals LLC from 2002 to 2016.
Ms. Day completed her undergraduate degree at the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AN2 THERAPEUTICS, INC.
0.10% | 2024-03-14 | 30,627 ( 0.10% ) | 99 538 $ | 2024-03-30 |
Lucy Day active positions
| Companies | Position | Start |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Director of Finance/CFO | 2019-10-31 |
Former positions of Lucy Day
| Companies | Position | End |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Director of Finance/CFO | 2016-07-31 |
| Centaur Pharmaceuticals, Inc. | Director of Finance/CFO | 2001-12-31 |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Corporate Officer/Principal | 1993-12-31 |
Training of Lucy Day
| University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
| AN2 THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Centaur Pharmaceuticals, Inc. | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Lucy Day
